Hemodialysis and Peritoneal Dialysis Market

Fresenius Medical Care (Germany) and Baxter International, Inc. (US) are Major Players in the Hemodialysis and Peritoneal Dialysis Market

The global hemodialysis and peritoneal dialysis market is projected to reach USD 99.2 billion by 2024 from USD 74.2 billion in 2019, at a CAGR of 6.0% during the forecast period. The growth of this market is largely driven by factors such as the increasing number of ESRD patients, growing prevalence of diabetes & hypertension (major causes of kidney failure), and the preference for dialysis treatments over kidney transplants (due to the lack of donors). Furthermore, the increasing number of dialysis centers, coupled with the increasing focus of market players on expanding their network through the acquisition of dialysis facilities, is adding to the growth opportunities in the hemodialysis and peritoneal dialysis market. However, the risks and complications associated with dialysis, low consumer awareness regarding kidney diseases, and reimbursement concerns are restricting the growth of this market to a certain extent.

The major players dominating the global hemodialysis and peritoneal dialysis market are Fresenius Medical Care AG & Co. KGaA (Germany), DaVita Healthcare Partners, Inc. (US), Baxter International, Inc. (US), and B. Braun Melsungen AG (Germany). The other players operating in this market include Ion Nipro Corporation (Japan), Cantel Medical Corporation (US), NIKKISO CO., LTD (Japan), Diaverum Healthcare Partners (Germany), Asahi Kasei Corporation (Japan), Medtronic Plc (Ireland), Rockwell Medical, Inc. (US), Becton, Dickinson and Company (US), Dialife Group (Switzerland), and Isopure Corp. (US), among others. The analysis of the market developments between 2015 and 2019 revealed that several growth strategies, such as product launches and strategic acquisitions, were adopted by market players to strengthen their product portfolios and maintain a competitive position in the hemodialysis and peritoneal dialysis market.

To know about the assumptions considered for the study download the pdf brochure

Fresenius Medical Care (Germany) is a leader in the global dialysis market, owing to its wide dialysis product portfolio and strong long-term geographical presence. The company has 42 operational sites across all continents and offers its products in more than 120 countries across North America, Europe, Latin America, the Asia Pacific, and Africa. Fresenius Medical Care primarily focuses on developing technologically advanced dialysis products for the treatment of kidney diseases to strengthen its position in the market. This is evident from the recent launch of new innovative dialysis products (such as 4008A dialysis machine, 6008 CAREsystem, and multiFiltratePRO). Besides new product launches, the company also focuses on strategic acquisitions and expansions to enhance its global presence and market share. The acquisition of NxStage Medical, Inc. (US) in 2019 will improve the home dialysis product portfolio of Fresenius and leverage its manufacturing, supply chain, and marketing competencies across the dialysis products and services industry.

Baxter International, Inc. (US) is another major players in the hemodialysis and peritoneal dialysis market. The company has a wide dialysis product portfolio and strong relationships with customers, including hospitals & clinics, kidney dialysis centers, purchasing organizations, and physicians. These are the major factors offering a competitive advantage to Baxter. The company primarily focuses on developing technologically advanced dialysis products and innovative dialysis therapies to strengthen its position in the global market. Baxter manufactures products in more than 20 countries and markets them in over 100 countries. Moreover, Baxter remains committed to significantly investing in R&D to develop breakthrough technologies through its research as well as collaborations and partnerships across the globe. As part of its growth strategy, the company has launched a number of products in the last three years, such as the AK 98 hemodialysis system (2017), AMIA automated peritoneal dialysis system (2016), HDx enabled by THERANOVA hemodialysis therapy (2016), and THERANOVA dialyzer (2016). The company also focuses on agreements and partnerships to expand its footprint in the global dialysis market. With its broad and technologically advanced product offerings, wide geographic presence, and strong growth strategies, the company is expected to witness sustained growth in the global hemodialysis and peritoneal dialysis market in the coming years.

Related Reports:

Hemodialysis & Peritoneal Dialysis Market by Product (Machines, Dialyzers, Concentrates, Dialysates, Catheters) Services, Modality (Conventional, CAPD, Nocturnal), End User (Hospital, Independent Dialysis Center, Home Dialysis) - Global Forecasts to 2024

Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441

Report Code
MD 2157
RI Published ON
Choose License Type
Request Customization
Speak to Analyst
Speak to Analyst
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
  • What are the Known and Unknown Adjacencies Impacting the Hemodialysis and Peritoneal Dialysis Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
©2021 MarketsandMarkets Research Private Ltd. All rights reserved